WuXi Biologics and CANbridge Launch China’s First Locally Developed Enzyme Replacement Therapy for Gaucher Disease

Enabled by WuXi Biologics' industry-leading integrated technology platform, velaglucerase-beta for injection has successfully advanced from concept to ...

May 19, 2025 | Monday | News
Fujirebio Receives FDA Clearance for First Blood-Based Test to Aid Alzheimer’s Diagnosis in the U.S.

Fujirebio announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Lumipulse® G pTau 217/&beta...

May 19, 2025 | Monday | News
QIAGEN Acquires Genoox for $70M to Expand AI-Powered Genomic Interpretation Portfolio

Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases Strengthens QIAGEN Digital Insigh...

May 13, 2025 | Tuesday | News
Eurofins Viracor Launches BAL Specimen Testing for NeXGen® Fungal/AFB NGS Assay to Transform Respiratory Infection Diagnostics

Eurofins Viracor, a leading specialty diagnostics laboratory, is proud to announce a groundbreaking advancement in respiratory infection diagnostics with...

May 08, 2025 | Thursday | News
Aspen Neuroscience Reports Positive 6-Month Data for ANPD001 in Parkinson’s Disease Ahead of IAPRD 2025 Presentation

ANPD001 was well tolerated with no major safety issues in low-dose cohort Patients showed early improvements in patient-reported and clinician-re...

May 08, 2025 | Thursday | News
Lantheus to Divest SPECT Business to SHINE Technologies Parent, Illuminated Holdings, in Strategic Refocus on PET and Radiopharmaceutical Innovation

Lantheus Holdings, Inc.the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better ...

May 07, 2025 | Wednesday | News
Can-Fite Secures $175M to Advance Oral A3AR Therapies into Phase III for Liver Cancer and Psoriasis

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small-molecule drugs for oncological and inflammatory diseases, toda...

May 06, 2025 | Tuesday | News
Boehringer Ingelheim and Tessellate Bio Forge €500M Deal to Develop First-in-Class Oral Cancer Therapies Targeting ALT-Dependent Tumors

Boehringer Ingelheim and Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality approaches, have entered into ...

April 23, 2025 | Wednesday | News
Intuitive Research Confirms Robotic-Assisted Surgery Expands Access to High-Quality Care in Medically Remote Regions

  Intuitive , a global leader in minimally invasive care and the pioneer of robotic-assisted surgery (RAS),  announced the publication of two st...

April 18, 2025 | Friday | Reports
Lecanemab Becomes First Approved Disease-Modifying Therapy for Early Alzheimer’s in the EU

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild de...

April 16, 2025 | Wednesday | News
Sanofi Expands Respiratory Pipeline With Promising Asthma Data and New COPD Study Plans

Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD New phase 2 data for amlitelimab show ...

April 15, 2025 | Tuesday | News
New Study Links SARS-CoV-2 Spike Protein Region to Autoantibody Production Potentially Driving Long COVID

 Long COVID or post COVID-19 syndrome, is a clinical entity observed in certain patients wherein symptoms of illness persist for at least several week...

April 10, 2025 | Thursday | News
Serina Therapeutics Raises $5M to Advance Novel Parkinson’s Therapy Toward Phase 1 Trial

Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform&tra...

April 09, 2025 | Wednesday | News
HNL Lab Medicine Partners with Northampton County to Offer Free Lead Testing for Children

HNL Lab Medicine, in partnership with Northampton County, is making it easier for families to access lead testing for children. Lead exposure remains a ser...

April 08, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close